Warning: Undefined array key "HITSTATS_API_KEY" in /var/www/html/application/config/config.php on line 107

Warning: Undefined array key "HITSTATS_SITE_IDENTIFIER" in /var/www/html/application/config/config.php on line 108
Camellia Regulatory News. Live CAM RNS. Regulatory News Articles for Camellia Plc Ord 10p

The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCamellia Regulatory News (CAM)

Share Price Information for Camellia (CAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,520.00
Bid: 4,500.00
Ask: 4,540.00
Change: 0.00 (0.00%)
Spread: 40.00 (0.889%)
Open: 4,520.00
High: 0.00
Low: 0.00
Prev. Close: 4,520.00
CAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

5 Aug 2014 10:16

RNS Number : 2742O
Camellia PLC
05 August 2014
 

5 August 2014

 

Camellia Plc

(the "Company")

 

Trading update

 

The Company wishes to make the following update on trading. As previously indicated, climactic conditions have affected a number of our agricultural operations for example in India and Bangladesh, where droughts have resulted in lost tea production and in California where our citrus crop was severely damaged by frost resulting in significantly reduced production. The lost production in these operations is unlikely to be recovered this year.

 

Our Indian tea sale prices have been satisfactory, but those in Bangladesh, as a result of cheaper imports, have been substantially lower than in 2013. Sale prices achieved recently in Bangladesh are showing some signs of recovery following an increase in import duties, but remain at materially lower levels than last year. 

 

The performance of our African tea businesses remains very disappointing due to substantially reduced tea sale prices in both Kenya and Malawi, although crops are ahead of budget. 

 

It is disappointing to report that a substantial loss has arisen from changes in the fair value of Biological Assets, primarily as a result of an 8 per cent. revaluation of the Malawi kwacha against the US$ during the period to 30 June 2014. 

 

As previously announced, trading at our Engineering division and at Duncan Lawrie are challenging, with problems remaining at AKD as a result of a protracted and ongoing legal dispute. At Duncan Lawrie income is lower than in the previous period due to reductions in banking and investment management income and additional costs that have been incurred as a consequence of certain changes to management. 

 

The cumulative effect of these items is that the results for the six months to 30 June 2014 are expected to be significantly below those achieved for the same period last year and are likely to show a loss. The profits lost in the first half are unlikely to be fully recouped in the second half of the year, though as is usual, the Company expects the results of the remainder of the year to show an improvement on the first half due to the cyclical nature of the business which is normally second half weighted.

 

The interim results will be announced on 28 August 2014.

 

Camellia Plc 01622 746655

Malcolm Perkins, Chairman

Anil Mathur, Finance Director

Julia Morton, Company Secretary

 

Charles Stanley Securities 020 7149 6000

Russell Cook

Carl Holmes

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCGCGDISBGBGSU
Date   Source Headline
28th Mar 202412:11 pmRNSUpdate on BF&M disposal
4th Jan 20244:00 pmRNSRefocussing investments & Bardsley England update
27th Sep 202310:03 amRNSTrading Update
1st Sep 20235:21 pmRNSInterim Report 2023
1st Sep 20237:00 amRNSHalf-year Report
17th Jul 20237:00 amRNSDirector Changes
9th Jun 202312:08 pmRNSResult of AGM
8th Jun 20237:00 amRNSAGM Trading Statement
6th Jun 202312:00 pmRNSSale of holding in BF&M Limited
11th May 202311:04 amRNSAnnual Report and Notice of AGM
4th May 20237:00 amRNSFinal Results
20th Mar 20237:00 amRNSChange of Registered Office Address
8th Mar 20237:00 amRNSTrading Update
30th Jan 20237:00 amRNSBF&M Strategic Review Conclusion
10th Jan 20239:01 amRNSCompletion of Disposal of ACS&T
19th Dec 20227:00 amRNSDisposal of ACS&T and Relocation of Head Office
7th Dec 20227:00 amRNSTrading Update
22nd Nov 20222:38 pmRNSTrading Update
6th Sep 20222:45 pmRNSInterim Report 2022 - Replacement
1st Sep 20224:00 pmRNSInterim Report 2022
1st Sep 20227:00 amRNSHalf-year Report
24th Aug 20227:00 amRNSTrading Update
1st Jul 202210:54 amRNSResults of Annual General Meeting - 30 June 2022
30th Jun 20227:00 amRNSBF&M Strategic Review
30th Jun 20227:00 amRNSAGM Trading Statement
9th Jun 202211:12 amRNSBoard Committee Changes
6th Jun 20225:22 pmRNSAnnual Report and Notice of AGM
31st May 20227:00 amRNSFinal Results
6th May 20227:00 amRNSDirector Changes and Trading Update
22nd Dec 20217:00 amRNSTrading Update
17th Nov 20217:00 amRNS100% Ownership of Bardsley England
2nd Nov 20217:00 amRNSDirectorate Change
2nd Sep 20212:36 pmRNSInterim Report 2021
2nd Sep 20217:00 amRNSHalf-year Report and changes to Board Committees
25th Aug 202112:42 pmRNSNotice of Interim Results
6th Aug 20218:30 amRNSDeath of Director
5th Aug 20217:00 amRNSSale of Abbey Metal Finishing
2nd Aug 20217:00 amRNSPurchase of Bardsley England
20th Jul 20212:00 pmRNSTrading Update
3rd Jun 20214:15 pmRNSResults of Annual General Meeting - 3 June 2021
3rd Jun 202112:00 pmRNSAGM Trading Statement
5th May 20214:00 pmRNSAnnual Report and Notice of AGM
4th May 20217:00 amRNSFinal Results and Directorate change
29th Apr 20214:30 pmRNSFinal Results - Date of Announcement
11th Feb 20218:00 amRNSTrading update and settlement of claims
16th Nov 20207:00 amRNSCompletion of asset disposal
2nd Nov 20207:15 amRNSGovernance changes
21st Oct 20204:04 pmRNSTrading update
12th Oct 20207:00 amRNSResponse to UK media reports on Kakuzi Plc
8th Oct 20205:15 pmRNSUpdate on African allegations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.